These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 7576228

  • 21. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
    Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K, Ito A.
    Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
    [Abstract] [Full Text] [Related]

  • 22. Activation mechanisms of matrix metalloproteinases.
    Nagase H.
    Biol Chem; 1997 Apr; 378(3-4):151-60. PubMed ID: 9165065
    [Abstract] [Full Text] [Related]

  • 23. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
    Tyagi SC, Kumar SG, Haas SJ, Reddy HK, Voelker DJ, Hayden MR, Demmy TL, Schmaltz RA, Curtis JJ.
    J Mol Cell Cardiol; 1996 Jul; 28(7):1415-28. PubMed ID: 8841929
    [Abstract] [Full Text] [Related]

  • 24. [Implication of extracellular matrix metalloproteinases in the course of chronic inflammatory airway diseases].
    Lechapt-Zalcman E, Escudier E.
    Morphologie; 2000 Jun; 84(265):45-9. PubMed ID: 11048298
    [Abstract] [Full Text] [Related]

  • 25. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
    Andrian E, Mostefaoui Y, Rouabhia M, Grenier D.
    J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
    [Abstract] [Full Text] [Related]

  • 26. Recent advances in the regulation of matrix metalloproteinase 2 activation: from basic research to clinical implication (Review).
    Yoshizaki T, Sato H, Furukawa M.
    Oncol Rep; 2002 Apr; 9(3):607-11. PubMed ID: 11956636
    [Abstract] [Full Text] [Related]

  • 27. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells.
    Tyagi SC, Lewis K, Pikes D, Marcello A, Mujumdar VS, Smiley LM, Moore CK.
    J Cell Physiol; 1998 Aug; 176(2):374-82. PubMed ID: 9648925
    [Abstract] [Full Text] [Related]

  • 28. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.
    Crawford HC, Matrisian LM.
    Invasion Metastasis; 1998 Aug; 14(1-6):234-45. PubMed ID: 7657516
    [Abstract] [Full Text] [Related]

  • 29. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 30. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM, Rowan AD, Cawston TE, Young DA.
    Arthritis Res Ther; 2006 May; 8(5):R142. PubMed ID: 16919164
    [Abstract] [Full Text] [Related]

  • 31. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.
    Cleutjens JP, Creemers EE.
    J Card Fail; 2002 Dec; 8(6 Suppl):S344-8. PubMed ID: 12555143
    [Abstract] [Full Text] [Related]

  • 32. Expression of metalloproteinases and their inhibitors in human trophoblast continuous cell lines.
    Morgan M, Kniss D, McDonnell S.
    Exp Cell Res; 1998 Jul 10; 242(1):18-26. PubMed ID: 9665798
    [Abstract] [Full Text] [Related]

  • 33. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes.
    He S, Prasanna G, Yorio T.
    Invest Ophthalmol Vis Sci; 2007 Aug 10; 48(8):3737-45. PubMed ID: 17652746
    [Abstract] [Full Text] [Related]

  • 34. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T, Yamanouchi K, Sato H, Tojo H, Seiki M, Tachi C.
    Placenta; 2004 Nov 10; 25(10):810-9. PubMed ID: 15451196
    [Abstract] [Full Text] [Related]

  • 35. Macrophage-derived MT1-MMP and increased MMP-2 activity are associated with glomerular damage in crescentic glomerulonephritis.
    Hayashi K, Horikoshi S, Osada S, Shofuda K, Shirato I, Tomino Y.
    J Pathol; 2000 Jul 10; 191(3):299-305. PubMed ID: 10878552
    [Abstract] [Full Text] [Related]

  • 36. Metalloproteinases in the pathogenesis of periodontal diseases.
    Kinane DF.
    Curr Opin Dent; 1992 Mar 10; 2():25-32. PubMed ID: 1520933
    [Abstract] [Full Text] [Related]

  • 37. Matrix metalloproteinases and their expression in mammary gland.
    Uria JA, Werb Z.
    Cell Res; 1998 Sep 10; 8(3):187-94. PubMed ID: 9791732
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Regulation of matrix metalloproteinase expression in tumor invasion.
    Westermarck J, Kähäri VM.
    FASEB J; 1999 May 10; 13(8):781-92. PubMed ID: 10224222
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.